
News|Articles|November 15, 2023
Enteric delivery of my API: How to make it right?
Author(s)Lonza
The enteric delivery of pharmaceuticals has long been a challenge for numerous reasons, including protecting the active pharmaceutical ingredients (APIs) from the harsh environment of the gastrointestinal tract and assuring consistent delivery and dosage in the small intestine. This paper reviews the challenges and the science that shows Lonza’s proposed hard capsule solution has been validated to provide acid protection, customization, and scalability.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Trending on Pharmaceutical Technology
1
FDA Releases Draft Guidance on Registering Pharmaceuticals for Human Use
2
West Launches New Prefillable Syringe System that Streamlines Biologic Delivery
3
PharmTech Weekly News Roundup – Week of January 19, 2026
4
ACG Introduces SuperPod for Drug Protection and Sustainability
5